Director, Scientific Applications, Partnerships and Product Strategy @ Station X (acquired by Roche)
Director, Scientific Liaison @ NextBio (acquired by Illumina)
Scientific Manager, Program Manager, Partner and Professional Services @ Ingenuity Systems (acquired by Qiagen)
Principal Scientist @ Iconix Biosciences (acquired by Entelos)
Antoaneta Vladimirova's Education
Massachusetts Institute of Technology
Executive Education, Artificial Intelligence in Health Care
2022 - 2022
University of California, Berkeley, Haas School of Business
Executive Education (Product Management)
2020 - 2020
New Jersey Institute of Technology
MSc, Computer Science
2001 - 2003
New York University School of Medicine
PhD (Molecular and Cell Biology)
1995 - 2000
Antoaneta Vladimirova's Skills
Biomarker Discovery
Drug Discovery
Genomics
Cancer
Infectious Diseases
Product Development
Program Management
Personalized Medicine
Systems Biology
Microarrays
Antoaneta Vladimirova's Summary
Antoaneta Vladimirova, based in California, United States, is currently a Director, Medical AI at Roche, bringing experience from previous roles at Roche and Station X (acquired by Roche). Antoaneta Vladimirova holds a 2022 - 2022 Executive Education, Artificial Intelligence in Health Care @ Massachusetts Institute of Technology. With a robust skill set that includes Biomarker Discovery, Drug Discovery, Genomics, Cancer, Infectious Diseases and more, Antoaneta Vladimirova contributes valuable insights to the industry. Antoaneta Vladimirova has 10 emails and 1 mobile phone number on RocketReach.